BMY - Bristol Sanofi Takeda gain positive CHMP recommendations
2024-04-26 14:32:03 ET
More on Bristol, Sanofi, Takeda
- Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off
- Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript
- Sanofi 2024 Q1 - Results - Earnings Call Presentation
- Takeda said to have left industry trade group BIO
- Bristol-Myers to cut 2,200 jobs as part of $1.5B cost savings plan